Last year, we made a huge transition: from Janssen Biologics to Johnson & Johnson Innovative Medicine, Biologics. So, why rebrand? It’s simple: to unite under one strong, international brand. We’ve always been part of Johnson & Johnson, and now our identity more strongly reflects that connection. Our new look captures the essence of who we are and how we are leading where medicine is going. ​​​​​​​

We never lost sight of the people we serve, and that remains at the heart of what we do under our new name. Continuing to listen and learn will fuel the development and delivery of transformational medicines for the future. Our updated identity is part of Johnson & Johnson’s changes worldwide, uniting both Medtech and Pharma under a common, recognizable brand. You have been introduced to the new logo, colors, and fonts that started rolling out last year – and it’s been full speed ahead ever since!

“It’s the cherry on top”

Incredible achievement

And what a year it’s been! An enormous amount of work has gone into this transition, thanks to all of you. Our buildings have been rebranded, new logos are proudly displayed, and our fleet of trucks has been completely rewrapped. It’s been nothing short of an incredible achievement in such a short time. A huge shoutout to all teams involved in Leiden, Sassenheim, and Schiphol who made it happen – your hard work has truly paid off!

“A huge shoutout to all teams involved”

From the JBVandaag to the JJIM. – And now, here we are with one final touch: the new name of this magazine. We’re officially saying goodbye to the JBVandaag and welcoming JJIM.bio – our new identity perfectly captured in an acronym for Johnson & Johnson Innovative Medicine. It’s the cherry on top of an exciting and transformative year! Together, we’re setting the stage for an inspiring, unified future under one global brand.

Yvonne Bos

Communications Johnson & Johnson Innovative Medicine, Biologics